2BBBullish & Bearish
Fulcrum Therapeutics, Inc. (FULC) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 25 out of 100.
Fulcrum Therapeutics, Inc.’s current 2BB score is 25 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 29 | Weak |
| Quality | 80 | Very Strong |
| Risk | 46 | Moderate |
| Founded | 2015 |
| Employees | 9 |
| 52-week range | $2.91 – $15.74 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | -0.1253 | — | $0.00 |
| 2026-10-27 | — | -0.1399 | — | $0.00 |
| 2026-08-05 | — | -0.2244 | — | $0.00 |
| 2026-04-27 | -0.25 | -0.3041 | — | $0.00 |